Literature DB >> 29720459

Impact of an antiretroviral stewardship strategy on medication error rates.

Katherine M Shea1, Athena Lv Hobbs2, Jason D Shumake3, Derek J Templet4, Eimeira Padilla-Tolentino4, Kristin E Mondy5.   

Abstract

PURPOSE: The impact of an antiretroviral stewardship strategy on medication error rates was evaluated.
METHODS: This single-center, retrospective, comparative cohort study included patients at least 18 years of age infected with human immunodeficiency virus (HIV) who were receiving antiretrovirals and admitted to the hospital. A multicomponent approach was developed and implemented and included modifications to the order-entry and verification system, pharmacist education, and a pharmacist-led antiretroviral therapy checklist. Pharmacists performed prospective audits using the checklist at the time of order verification. To assess the impact of the intervention, a retrospective review was performed before and after implementation to assess antiretroviral errors.
RESULTS: Totals of 208 and 24 errors were identified before and after the intervention, respectively, resulting in a significant reduction in the overall error rate (p < 0.001). In the postintervention group, significantly lower medication error rates were found in both patient admissions containing at least 1 medication error (p < 0.001) and those with 2 or more errors (p < 0.001). Significant reductions were also identified in each error type, including incorrect/incomplete medication regimen, incorrect dosing regimen, incorrect renal dose adjustment, incorrect administration, and the presence of a major drug-drug interaction. A regression tree selected ritonavir as the only specific medication that best predicted more errors preintervention (p < 0.001); however, no antiretrovirals reliably predicted errors postintervention.
CONCLUSION: An antiretroviral stewardship strategy for hospitalized HIV patients including prospective audit by staff pharmacists through use of an antiretroviral medication therapy checklist at the time of order verification decreased error rates.
Copyright © 2018 by the American Society of Health-System Pharmacists, Inc. All rights reserved.

Entities:  

Keywords:  HIV/AIDS; antiretrovirals; medication errors; medication safety

Mesh:

Substances:

Year:  2018        PMID: 29720459     DOI: 10.2146/ajhp170420

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  5 in total

1.  Impact of Pharmacist-Driven Antiretroviral Stewardship and Transitions of Care Interventions on Persons With Human Immunodeficiency Virus.

Authors:  Marisa B Brizzi; Rodrigo M Burgos; Thomas D Chiampas; Sarah M Michienzi; Renata Smith; Paa Kwesi Yanful; Melissa E Badowski
Journal:  Open Forum Infect Dis       Date:  2020-08-24       Impact factor: 3.835

Review 2.  Interventions to reduce medication errors in adult medical and surgical settings: a systematic review.

Authors:  Elizabeth Manias; Snezana Kusljic; Angela Wu
Journal:  Ther Adv Drug Saf       Date:  2020-11-12

3.  Impact of an Antiretroviral Stewardship Team on the Care of Patients With Human Immunodeficiency Virus Infection Admitted to an Academic Medical Center.

Authors:  Ashley M DePuy; Rafik Samuel; Kerry M Mohrien; Elijah B Clayton; David E Koren
Journal:  Open Forum Infect Dis       Date:  2019-06-24       Impact factor: 3.835

4.  A Call to Action: The Role of Antiretroviral Stewardship in Inpatient Practice, a Joint Policy Paper of the Infectious Diseases Society of America, HIV Medicine Association, and American Academy of HIV Medicine.

Authors:  David E Koren; Kimberly K Scarsi; Eric K Farmer; Agnes Cha; Jessica L Adams; Neha Sheth Pandit; Jennifer Chang; James Scott; W David Hardy
Journal:  Clin Infect Dis       Date:  2020-05-23       Impact factor: 9.079

Review 5.  Antiretroviral Stewardship: A Review of Published Outcomes with Recommendations for Program Implementation.

Authors:  Sarah M Michienzi; Amber F Ladak; Sarah E Pérez; Daniel B Chastain
Journal:  J Int Assoc Provid AIDS Care       Date:  2020 Jan-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.